{
    "id": "RDES5",
    "name": "Liver Imaging",
    "description": "The Liver Imaging Reporting and Data System (LI-RADS) was created to standardize the reporting and data collection of CT and MR imaging for hepatocellular carcinoma (HCC). ",
    "version": {
        "name": "Liver Imaging",
        "version_date": "00\/00\/0000",
        "status": "Proposed"
    },
    "url": "https:\/\/api3.rsna.org\/radelement\/public\/sets\/5",
    "index_codes": [
        {
            "system": "RADLEX",
            "code": "RID49823",
            "display": "LI-RADS assessment",
            "href": "http:\/\/www.radlex.org\/RID\/RID49823"
        }
    ],
    "body_parts": [
        {
            "name": "Liver",
            "index_codes": {
                "system": "RADLEX",
                "code": "RID58",
                "display": "liver",
                "href": "http:\/\/www.radlex.org\/RID\/RID58"
            }
        }
    ],
    "authors": {
        "person": [],
        "organization": [
            {
                "name": "Radiological Society of North America",
                "abbreviation": "RSNA",
                "url": "https:\/\/www.rsna.org\/",
                "comment": "comment",
                "role": null
            }
        ]
    },
    "history": [],
    "specialty": [
        {
            "abbreviation": "GI",
            "name": "Gastrointestinal Radiology"
        },
        {
            "abbreviation": "AB",
            "name": "Abdominal Radiology"
        }
    ],
    "elements": [
        {
            "id": "RDE65",
            "parent_id": 5,
            "name": "LI-RADS assessment category",
            "short_name": "LR",
            "editor": "cek",
            "instructions": "",
            "synonyms": "",
            "definition": "Ordinal score assigned to an observation indicating its likelihood of hepatocellular carcinoma (HCC) or malignancy. ",
            "question": "",
            "version": {
                "name": "2014",
                "version_date": "01\/01\/2014",
                "status_date": "01\/01\/2014",
                "status": "Published"
            },
            "index_codes": [
                {
                    "system": "RADLEX",
                    "code": "RID49794",
                    "display": "LR-1",
                    "href": "http:\/\/www.radlex.org\/RID\/RID49794"
                },
                {
                    "system": "RADLEX",
                    "code": "RID49795",
                    "display": "LR-2",
                    "href": "http:\/\/www.radlex.org\/RID\/RID49795"
                },
                {
                    "system": "RADLEX",
                    "code": "RID49796",
                    "display": "LR-3",
                    "href": "http:\/\/www.radlex.org\/RID\/RID49796"
                },
                {
                    "system": "RADLEX",
                    "code": "RID49797",
                    "display": "LR-4",
                    "href": "http:\/\/www.radlex.org\/RID\/RID49797"
                },
                {
                    "system": "RADLEX",
                    "code": "RID49799",
                    "display": "LR-5",
                    "href": "http:\/\/www.radlex.org\/RID\/RID49799"
                },
                {
                    "system": "RADLEX",
                    "code": "RID49802",
                    "display": "LR-5V",
                    "href": "http:\/\/www.radlex.org\/RID\/RID49802"
                },
                {
                    "system": "RADLEX",
                    "code": "RID49804",
                    "display": "LR-Treated",
                    "href": "http:\/\/www.radlex.org\/RID\/RID49804"
                },
                {
                    "system": "RADLEX",
                    "code": "RID49803",
                    "display": "LR-M",
                    "href": "http:\/\/www.radlex.org\/RID\/RID49803"
                },
                {
                    "system": "RADLEX",
                    "code": "RID49823",
                    "display": "LI-RADS assessment",
                    "href": "http:\/\/www.radlex.org\/RID\/RID49823"
                }
            ],
            "authors": {
                "person": [],
                "organization": []
            },
            "history": [],
            "specialty": [],
            "references": [],
            "source": "http:\/\/www.acr.org\/Quality-Safety\/Resources\/LIRADS",
            "value_set": {
                "cardinality": {
                    "min_cardinality": 1,
                    "max_cardinality": 1
                },
                "value_min_max": {
                    "value_min": 1,
                    "value_max": 1
                },
                "step_value": null,
                "unit": "",
                "value_type": "valueSet",
                "value_size": 0,
                "values": [
                    {
                        "value": "LR-1",
                        "name": "Definitely benign",
                        "definition": "100% certainty observation is benign.  \r\n\r\nObservation with: Imaging features diagnostic of a benign entity\r\nor Definite spontaneous disappearance at follow up\r\n\r\nExamples: Observations that may be categorized as LR-1: definite benign entities.\r\n\r\nReporting: LR-1 observations may be reported at radiologist\u2019s discretion.\r\nSince LR-1 observations are definitely benign, they may be reported or not reported at the radiologist's discretion\r\nLR-1 observations may be reported in aggregate."
                    },
                    {
                        "value": "LR-2",
                        "name": "Probably benign",
                        "definition": "High likelihood observation is benign.\r\n\r\nObservation with imaging features suggestive but not diagnostic of a benign entity.\r\n\r\nExamples:  Observations that may be categorized as LR-2: probable benign entities.\r\n\r\nReporting:  \r\n\r\nLR-2 observations may be reported at the radiologist\u2019s discretion.\r\n\r\nSince LR-2 observations are likely benign, they may be reported or not reported at the radiologist's discretion.\r\n\r\nLR-2 observations may be reported in aggregate.\r\n\r\nManagement implications:\r\n\r\nContinued routine surveillance usually is appropriate."
                    },
                    {
                        "value": "LR-3",
                        "name": "Intermediate probability for HCC",
                        "definition": "Observation that does not meet unequivocal criteria for other LI-RADS categories. \r\n\r\nCriteria:  Not definite benign entity, not probable benign entity, not non-HCC malignancy, not tumor in vein and one of the following:\r\n\r\nMass with hepatic arterial phase hypo- or isoenhancement\r\n< 20mm mass with \u2264 1 of following: \u201cwashout\u201d, \u201ccapsule\u201d, and threshold growth\r\n\u2265 20mm mass with none of following: \u201cwashout\u201d, \u201ccapsule\u201d, and threshold growth\r\nMass with hepatic arterial phase hyperenhancement\r\n< 20mm mass with none of following: \u201cwashout\u201d, \u201ccapsule\u201d, and  threshold growth"
                    },
                    {
                        "value": "LR-4",
                        "name": "Probably HCC",
                        "definition": "Observation with imaging features suggestive but not diagnostic of HCC. "
                    },
                    {
                        "value": "LR-5",
                        "name": "Definitely HCC",
                        "definition": "Observation with imaging features diagnostic of HCC. "
                    },
                    {
                        "value": "LR-5V",
                        "name": "Definite tumor in vein",
                        "definition": "Observation associated with definite tumor in vein.\r\n\r\nCriterion: Definite enhancing soft tissue in vein."
                    },
                    {
                        "value": "LR-M",
                        "name": "Probably malignant, not specific for HCC",
                        "definition": "Observation with one or more imaging features that favor non-HCC malignancy."
                    },
                    {
                        "value": "LR-Treated",
                        "name": "Treated observation",
                        "definition": "An observation that has undergone loco-regional treatment.\r\n\r\nComments: \r\nLR-Treated does not imply that loco-regional treatment was successful.\r\nResidual or recurrent HCC may be present."
                    }
                ]
            }
        },
        {
            "id": "RDE80",
            "parent_id": 5,
            "name": "Tumor in vein",
            "short_name": "",
            "editor": "",
            "instructions": "<ul><li>Observations thought to definitely represent tumor in vein should be categorized LR-5V.<\/li><li>Observations thought to probably represent tumor in vein should be categorized as LR-3, LR-4, or LR-5 based on Table.<\/li><li>Observations that are indeterminate for tumor in vein should be categorized as LR-3, LR-4, or LR-5 based on Table.<\/li><\/ul>",
            "synonyms": "",
            "definition": "Presence of tumor in vein lumen.",
            "question": "",
            "version": {
                "name": "2014",
                "version_date": "09\/02\/2016",
                "status_date": "09\/02\/2016",
                "status": "Proposed"
            },
            "index_codes": [
                {
                    "system": "SNOMEDCT",
                    "code": "52101004",
                    "display": "present",
                    "href": "http:\/\/purl.bioontology.org\/ontology\/SNOMEDCT\/52101004"
                },
                {
                    "system": "RADLEX",
                    "code": "RID28472",
                    "display": "present",
                    "href": "http:\/\/www.radlex.org\/RID\/RID28472"
                },
                {
                    "system": "RADLEX",
                    "code": "RID39483",
                    "display": "tumor in vein",
                    "href": "http:\/\/www.radlex.org\/RID\/RID39483"
                },
                {
                    "system": "SNOMEDCT",
                    "code": "2667000",
                    "display": "absent",
                    "href": "http:\/\/purl.bioontology.org\/ontology\/SNOMEDCT\/2667000"
                },
                {
                    "system": "RADLEX",
                    "code": "RID28473",
                    "display": "absent",
                    "href": "http:\/\/www.radlex.org\/RID\/RID28473"
                }
            ],
            "authors": {
                "person": [],
                "organization": []
            },
            "history": [],
            "specialty": [],
            "references": [],
            "source": "",
            "value_set": {
                "cardinality": {
                    "min_cardinality": 1,
                    "max_cardinality": 1
                },
                "value_min_max": {
                    "value_min": 1,
                    "value_max": 1
                },
                "step_value": 0,
                "unit": "",
                "value_type": "valueSet",
                "value_size": 0,
                "values": [
                    {
                        "value": "1",
                        "name": "Present",
                        "definition": null
                    },
                    {
                        "value": "0",
                        "name": "Absent",
                        "definition": null
                    }
                ]
            }
        },
        {
            "id": "RDE81",
            "parent_id": 5,
            "name": "Diameter",
            "short_name": "",
            "editor": "",
            "instructions": "Diameter should be measured in the sequence, phase, and imaging plane in which the margins are most sharply demarcated and in which there is no anatomic distortion. If margins are sharply demarcated on more than one sequence or phase, do not measure in the arterial phase.",
            "synonyms": "",
            "definition": "The largest dimension (outer edge to outer edge) of an observation, measured in millimeters.",
            "question": "",
            "version": {
                "name": "",
                "version_date": "09\/02\/2016",
                "status_date": "09\/02\/2016",
                "status": "Proposed"
            },
            "index_codes": [],
            "authors": {
                "person": [],
                "organization": []
            },
            "history": [],
            "specialty": [],
            "references": [],
            "source": "",
            "integer_value": {
                "cardinality": {
                    "min_cardinality": 1,
                    "max_cardinality": 1
                },
                "value_min_max": {
                    "value_min": 0,
                    "value_max": 999
                },
                "step_value": 1,
                "unit": "mm",
                "value_type": "integer",
                "value_size": 0,
                "values": []
            }
        },
        {
            "id": "RDE83",
            "parent_id": 5,
            "name": "Capsule appearance",
            "short_name": "",
            "editor": "",
            "instructions": "The rim's degree of arterial phase enhancement is not relevant for characterization of this feature. The rim's attenuation\/intensity on non-vascular phase images is not relevant for characterization of this feature.",
            "synonyms": "",
            "definition": "Peripheral rim of smooth hyper-enhancement in the portal venous phase ordelayed phase that unequivocally is thicker or more conspicuous than the rim's surrounding background nodule.",
            "question": "",
            "version": {
                "name": "",
                "version_date": "09\/02\/2016",
                "status_date": "09\/02\/2016",
                "status": "Proposed"
            },
            "index_codes": [
                {
                    "system": "RADLEX",
                    "code": "RID39146",
                    "display": "capsule appearance",
                    "href": "http:\/\/www.radlex.org\/RID\/RID39146"
                },
                {
                    "system": "SNOMEDCT",
                    "code": "10200004",
                    "display": "liver",
                    "href": "http:\/\/purl.bioontology.org\/ontology\/SNOMEDCT\/10200004"
                },
                {
                    "system": "SNOMEDCT",
                    "code": "181268008",
                    "display": "liver",
                    "href": "http:\/\/purl.bioontology.org\/ontology\/SNOMEDCT\/181268008"
                },
                {
                    "system": "RADLEX",
                    "code": "RID58",
                    "display": "liver",
                    "href": "http:\/\/www.radlex.org\/RID\/RID58"
                }
            ],
            "authors": {
                "person": [],
                "organization": []
            },
            "history": [],
            "specialty": [],
            "references": [],
            "source": "",
            "value_set": {
                "cardinality": {
                    "min_cardinality": 1,
                    "max_cardinality": 1
                },
                "value_min_max": {
                    "value_min": 1,
                    "value_max": 1
                },
                "step_value": 0,
                "unit": "",
                "value_type": "valueSet",
                "value_size": 0,
                "values": [
                    {
                        "value": "Present",
                        "name": "Capsule appearance.",
                        "definition": null
                    },
                    {
                        "value": "Absent ",
                        "name": "No capsule appearance.",
                        "definition": null
                    }
                ]
            }
        },
        {
            "id": "RDE84",
            "parent_id": 5,
            "name": "Threshold growth",
            "short_name": "",
            "editor": "",
            "instructions": "Applies to masses; it does not apply to observations that are not masses (e.g., perfusion alterations, hepatic fat deposition). Growth should be assessed on images acquired in the same plane and, if possible, the same phase or sequence. If margins are sharply demarcated on more than one sequence or phase, do not measure in the arterial phase. A new &gt; 10 mm mass also represents threshold growth, regardless of the time interval.",
            "synonyms": "",
            "definition": "Increase in diameter of a mass compared to its baseline by a minimum of 5 mm AND depending on the time interval between examinations, by the following amounts:<ul><li>&lt;6 months: &gt;50% diameter increase<\/li><li>&gt;6 months: &gt;100% diameter increase<\/li><\/ul>",
            "question": "",
            "version": {
                "name": "",
                "version_date": "09\/02\/2016",
                "status_date": "09\/02\/2016",
                "status": "Proposed"
            },
            "index_codes": [],
            "authors": {
                "person": [],
                "organization": []
            },
            "history": [],
            "specialty": [],
            "references": [],
            "source": "",
            "value_set": {
                "cardinality": {
                    "min_cardinality": 1,
                    "max_cardinality": 1
                },
                "value_min_max": {
                    "value_min": 1,
                    "value_max": 1
                },
                "step_value": 0,
                "unit": "",
                "value_type": "valueSet",
                "value_size": 0,
                "values": [
                    {
                        "value": "Present",
                        "name": "Threshold growth",
                        "definition": null
                    },
                    {
                        "value": "Absent",
                        "name": "No threshold growth",
                        "definition": null
                    }
                ]
            }
        },
        {
            "id": "RDE85",
            "parent_id": 5,
            "name": "Washout",
            "short_name": "",
            "editor": "",
            "instructions": "",
            "synonyms": "",
            "definition": "Enhancement in the portal venous or delayed phases that unequivocally is less than that of liver.",
            "question": "",
            "version": {
                "name": "",
                "version_date": "09\/02\/2016",
                "status_date": "09\/02\/2016",
                "status": "Proposed"
            },
            "index_codes": [],
            "authors": {
                "person": [],
                "organization": []
            },
            "history": [],
            "specialty": [],
            "references": [],
            "source": "",
            "value_set": {
                "cardinality": {
                    "min_cardinality": 1,
                    "max_cardinality": 1
                },
                "value_min_max": {
                    "value_min": 1,
                    "value_max": 1
                },
                "step_value": null,
                "unit": "",
                "value_type": "valueSet",
                "value_size": 0,
                "values": [
                    {
                        "value": "Present",
                        "name": "Washout",
                        "definition": null
                    },
                    {
                        "value": "Absent",
                        "name": "No washout",
                        "definition": null
                    }
                ]
            }
        },
        {
            "id": "RDE86",
            "parent_id": 5,
            "name": "Hepatobiliary phase hypointensity",
            "short_name": "",
            "editor": "",
            "instructions": "Usage:<ul><li>An observation that is not definitely or probably benign but is hypo-intense in the hepatobiliary phase and iso-intense on all other sequences should be categorized LR &ge; 3. These features should prompt a careful review of all other pre- and postcontrast sequences to identify subtle imaging features that might have been missed initially. <\/li><li>Ancillary feature that may favor malignancy<\/li><\/ul> If unsure whether an observation in the hepatobiliary phase is hypointense vs. isointense:<ul><li>Characterize as hepatobiliary phase isointense<\/li><\/ul>",
            "synonyms": "",
            "definition": "Intensity in the hepatobiliary phase that unequivocally is less than that of the surrounding liver.",
            "question": "",
            "version": {
                "name": "",
                "version_date": "09\/02\/2016",
                "status_date": "09\/02\/2016",
                "status": "Proposed"
            },
            "index_codes": [],
            "authors": {
                "person": [],
                "organization": []
            },
            "history": [],
            "specialty": [],
            "references": [],
            "source": "",
            "value_set": {
                "cardinality": {
                    "min_cardinality": 1,
                    "max_cardinality": 1
                },
                "value_min_max": {
                    "value_min": 1,
                    "value_max": 1
                },
                "step_value": 0,
                "unit": "",
                "value_type": "valueSet",
                "value_size": 0,
                "values": [
                    {
                        "value": "Present",
                        "name": "Hepatobiliary phase hypointensity",
                        "definition": null
                    },
                    {
                        "value": "Absent",
                        "name": "Hepatobiliary phase iso- or hyperintensity",
                        "definition": null
                    }
                ]
            }
        },
        {
            "id": "RDE87",
            "parent_id": 5,
            "name": "Mild-moderate T2 hyperintensity",
            "short_name": "",
            "editor": "",
            "instructions": "Usage:  <ul><li>Mild-moderate T2 hyper-intensity is an ancillary feature favoring malignancy. <\/li><li>Radiologists at their discretion may apply mild-moderate T2 hyperintensity to upgrade category (up to LR-4).<\/li><\/ul> If unsure about feature: <ul><li>Do not characterize as mild-moderate T2 hyperintensity.<\/li><\/ul>",
            "synonyms": "",
            "definition": "Having mildly or moderately higher signal intensity on T2w images than liver.",
            "question": "",
            "version": {
                "name": "",
                "version_date": "09\/02\/2016",
                "status_date": "09\/02\/2016",
                "status": "Proposed"
            },
            "index_codes": [],
            "authors": {
                "person": [],
                "organization": []
            },
            "history": [],
            "specialty": [],
            "references": [],
            "source": "",
            "value_set": {
                "cardinality": {
                    "min_cardinality": 1,
                    "max_cardinality": 1
                },
                "value_min_max": {
                    "value_min": 1,
                    "value_max": 1
                },
                "step_value": null,
                "unit": "",
                "value_type": "valueSet",
                "value_size": 0,
                "values": [
                    {
                        "value": "Present",
                        "name": "Mild-moderate T2 hyperintensity",
                        "definition": null
                    },
                    {
                        "value": "Absent",
                        "name": "Not mild-moderate T2 hyperintensity",
                        "definition": null
                    }
                ]
            }
        },
        {
            "id": "RDE88",
            "parent_id": 5,
            "name": "T2 signal intensity",
            "short_name": "",
            "editor": "",
            "instructions": "",
            "synonyms": "",
            "definition": "Signal intensity relative to liver on T2w images.",
            "question": "",
            "version": {
                "name": "",
                "version_date": "09\/02\/2016",
                "status_date": "09\/02\/2016",
                "status": "Proposed"
            },
            "index_codes": [],
            "authors": {
                "person": [],
                "organization": []
            },
            "history": [],
            "specialty": [],
            "references": [],
            "source": "",
            "value_set": {
                "cardinality": {
                    "min_cardinality": 1,
                    "max_cardinality": 1
                },
                "value_min_max": {
                    "value_min": null,
                    "value_max": null
                },
                "step_value": null,
                "unit": "",
                "value_type": "valueSet",
                "value_size": 0,
                "values": [
                    {
                        "value": "1",
                        "name": "Mild-moderate T2 hyperintensity, well-defined",
                        "definition": null
                    },
                    {
                        "value": "2",
                        "name": "Mild-moderate T2 hyperintensity, ill-defined",
                        "definition": null
                    },
                    {
                        "value": "3",
                        "name": "Marked T2 hyperintensity",
                        "definition": null
                    },
                    {
                        "value": "4",
                        "name": "Mild T2 hypointensity",
                        "definition": null
                    }
                ]
            }
        },
        {
            "id": "RDE89",
            "parent_id": 5,
            "name": "Restricted diffusion",
            "short_name": "",
            "editor": "",
            "instructions": "Applies to observations that unequivocally:\r\n<ul>\r\n<li>Are hyperintense relative to liver on DW images acquired with at least moderate diffusion weighting (e.g., b&nbsp;&ge;&nbsp;400&nbsp;s\/mm<sup>2<\/sup>) AND<\/li>\r\n<li>If ADC map is generated, have low apparent diffusion coefficient (ADC)<\/li>\r\n<\/ul>\r\nIf unsure about restricted diffusion:\r\n<ul><li>Do not characterize as restricted diffusion.<\/li><\/ul>",
            "synonyms": "",
            "definition": "Having higher signal intensity, not attributable solely to T2 shine-through, than liver on diffusion-weighted (DW) images. ",
            "question": "",
            "version": {
                "name": "",
                "version_date": "09\/02\/2016",
                "status_date": "09\/02\/2016",
                "status": "Proposed"
            },
            "index_codes": [],
            "authors": {
                "person": [],
                "organization": []
            },
            "history": [],
            "specialty": [],
            "references": [],
            "source": "",
            "value_set": {
                "cardinality": {
                    "min_cardinality": 1,
                    "max_cardinality": 1
                },
                "value_min_max": {
                    "value_min": 1,
                    "value_max": 1
                },
                "step_value": 0,
                "unit": "",
                "value_type": "valueSet",
                "value_size": 0,
                "values": [
                    {
                        "value": "Present",
                        "name": "Restricted diffusion",
                        "definition": null
                    },
                    {
                        "value": "Absent",
                        "name": "No restricted diffusion",
                        "definition": null
                    }
                ]
            }
        },
        {
            "id": "RDE90",
            "parent_id": 5,
            "name": "Mosaic architecture",
            "short_name": "",
            "editor": "",
            "instructions": "Mosaic architecture is an ancillary feature favoring malignancy. \r\n<ul>\r\n<li>Mosaic architecture specifically favors HCC as opposed to malignancy in general. <\/li>\r\n<li>Radiologists at their discretion may apply mosaic architecture to upgrade category (up to LR-4) for such masses.<\/li>\r\n<\/ul>\r\nIf unsure about feature:\r\n<ul><li>Do not characterize as mosaic architecture.<\/li><\/ul>\r\n",
            "synonyms": "",
            "definition": "Observation that appears to consist of nodules or compartments with differing appearances (enhancement, attenuation, intensity).  This term can also be applied to lesions with internal enhancing septations. The nodules, compartments, or septations appear randomly distributed within the observation.",
            "question": "",
            "version": {
                "name": "",
                "version_date": "09\/02\/2016",
                "status_date": "09\/02\/2016",
                "status": "Proposed"
            },
            "index_codes": [],
            "authors": {
                "person": [],
                "organization": []
            },
            "history": [],
            "specialty": [],
            "references": [],
            "source": "",
            "value_set": {
                "cardinality": {
                    "min_cardinality": 1,
                    "max_cardinality": 1
                },
                "value_min_max": {
                    "value_min": 1,
                    "value_max": 1
                },
                "step_value": 0,
                "unit": "",
                "value_type": "valueSet",
                "value_size": 0,
                "values": [
                    {
                        "value": "Present",
                        "name": "Mosaic architecture",
                        "definition": null
                    },
                    {
                        "value": "Absent",
                        "name": "No mosaic architecture",
                        "definition": null
                    }
                ]
            }
        },
        {
            "id": "RDE91",
            "parent_id": 5,
            "name": "Intralesional fat",
            "short_name": "",
            "editor": "",
            "instructions": "Usage:\r\n<ul>\r\n<li>Applies to masses that, in whole or in part, unequivocally have higher fat content than background liver.<\/li>\r\n<li>In patients at risk for HCC, intra-lesional fat is an ancillary feature favoring malignancy. Intra-lesional fat specifically favors HCC as opposed to malignancy in general.<\/li>\r\n<li>Radiologists at their discretion may apply intra-lesional fat to upgrade category (up to LR-4).<\/li>\r\n<li>MRI is more sensitive and specific for detection of intra-lesional fat than CT.\r\n<li>At MRI, a mass may be characterized as having intra-lesional fat if: \r\n <ul><li>it shows signal loss on out-of-phase (OP) compared to in-phase (IP) gradient echo images or it shows signal loss on fat-suppressed compared to non-fat-suppressed images AND <\/li>\r\n <li>its degree of signal loss is greater than that of liver (i.e., it has higher fractional fat content than liver).<\/li>\r\n <\/ul><\/li>\r\n<li>At CT, a mass may be characterized as having intra-lesional fat if: \r\n <ul><li>its attenuation measures &lt; 40 Hounsfield units (HU) on unenhanced images AND its attenuation is less than that of liver (i.e., it has higher fractional fat content than liver). <\/li><\/ul>\r\n<\/li><\/ul>\r\nIf unsure about feature: Do not characterize as intra-lesional fat.",
            "synonyms": "",
            "definition": "Presence of lipid in higher concentration within a mass than in background reference tissue (e.g., liver).",
            "question": "",
            "version": {
                "name": "",
                "version_date": "09\/02\/2016",
                "status_date": "09\/02\/2016",
                "status": "Proposed"
            },
            "index_codes": [],
            "authors": {
                "person": [],
                "organization": []
            },
            "history": [],
            "specialty": [],
            "references": [],
            "source": "",
            "value_set": {
                "cardinality": {
                    "min_cardinality": 1,
                    "max_cardinality": 1
                },
                "value_min_max": {
                    "value_min": 1,
                    "value_max": 1
                },
                "step_value": 0,
                "unit": "",
                "value_type": "valueSet",
                "value_size": 0,
                "values": [
                    {
                        "value": "Present",
                        "name": "Intralesional fat",
                        "definition": null
                    },
                    {
                        "value": "Absent",
                        "name": "No intralesional fat",
                        "definition": null
                    }
                ]
            }
        },
        {
            "id": "RDE82",
            "parent_id": 5,
            "name": "Arterial phase hyperenhancement",
            "short_name": "",
            "editor": "",
            "instructions": "If unsure about arterial phase hyperenhancement: Characterize as hypo- or isoenhancement.",
            "synonyms": "",
            "definition": "Enhancement in the arterial phase that unequivocally is greater than that of liver.",
            "question": "",
            "version": {
                "name": "",
                "version_date": "09\/02\/2016",
                "status_date": "09\/02\/2016",
                "status": "Proposed"
            },
            "index_codes": [],
            "authors": {
                "person": [],
                "organization": []
            },
            "history": [],
            "specialty": [],
            "references": [],
            "source": "",
            "value_set": {
                "cardinality": {
                    "min_cardinality": 1,
                    "max_cardinality": 1
                },
                "value_min_max": {
                    "value_min": 0,
                    "value_max": 0
                },
                "step_value": 0,
                "unit": "",
                "value_type": "valueSet",
                "value_size": 0,
                "values": [
                    {
                        "value": "Present",
                        "name": "Arterial phase hyperenhancement",
                        "definition": null
                    },
                    {
                        "value": "Absent",
                        "name": "Arterial phase hypo- or isoenhancement",
                        "definition": null
                    }
                ]
            }
        }
    ],
    "references": []
},
"meta": {
    "contactName": "Aranda, Mario",
    "isUserFavorite": false,
    "parent": null,
    "source": [
        ""
    ]
    }
